|
|
|
|
RepRegen bioactive glass promotes hard tissue repair
RepRegen, the biomaterials developer previously known as BioCeramic Therapeutics, has announced that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and...
|
|
|
RepRegen reports potential advance in the repair and regeneration of hard-tissue, such as bone
The Company's hard-tissue platform is based on 'smart' bioceramics designed to be used, initially, by orthopaedic product manufacturers and surgeons.A Bioceramics have been helping improve the quality of life for millions of people over the past several...
|
|
|
RepRegen Reports Potential Advance In The Repair And Regeneration Of Hard-Tissue, Such As Bone
RepRegen, the 'smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and...
|
|
|
RepRegen Reports Potential Advance In The Repair And Regeneration Of Hard-Tissue, Such As Bone
RepRegen, the 'smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and...
|
|
|
Medical News: RepRegen Reports Potential Advance In The Repair And Regeneration Of Hard-Tissue, Such As Bone
RepRegen, the 'smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and...
|
|
|
RepRegen's Strontium-based bioactive glass platform encourages osteoblast cell activity and proliferation
RepRegen, the smart biomaterials company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and...
|
|
|
RepRegen Reports Potential Advance in the Repair and Regeneration of Hard-Tissue, Such as Bone
Companies mentioned in this article: RepRegen Ltd.NEW ORLEANS -- (BUSINESS WIRE) -- RepRegen, the smart biomaterials company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented ...
|
|
|
RepRegen„ Reports Potential Advance in the Repair and Regeneration of Hard-Tissue, Such as Bone
RepRegen„, the smart biomaterials company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity...
|
|
|
Deep sedimentation of acantharian cysts -- a reproductive strategy?
Spore-like reproductive cysts of enigmatic organisms called acantharians rapidly sink from surface waters to the deep ocean in certain regions, according to new research.Scientists suspect that this is part of an extraordinary reproductive strategy, which...
|
|
|
Thermal Spray Technology: Findings in thermal spray technology reported from Forschungszentrum Julich GmbH
Study data from University of Toronto update knowledge of thermal spray technology ; 2010 FEB 16 - (VerticalNews.com) -- According to recent research from Toronto, Canada, "Atmospheric plasma spraying (APS) is attractive for manufacturing solid oxide fuel cells...
|
|
|
Radiation, injections reduce treatment burden for age-related macular degeneration
San Francisco?A preliminary study of epimacular brachytherapy showed that radiation and anti-vascular endothelial growth factor (VEGF) injections reduced the treatment burden and maintained the visual acuity (VA) in patients with neovascular age-related macular...
|
|
|
Reducing vertebral fractures
tebral fractures Natalya AndersonNatalya Anderson reviews a study which found that the risk of vertebral fracture in young postmenopausal women could be reduced with strontium ranelate treatment Strontium ranelate may reduce the risk of vertebral...
|
|
|
New Undertsanding of Catalysts
A collaboration between researchers at Northwestern University's Center for Catalysis and scientists at Oxford University has produced a new approach for understanding surfaces, particularly metal oxide surfaces, widely used in industry as supports for...
|
|
|
Surface science goes inorganic
Posted In: Life Sciences A collaboration between researchers at Northwestern University's Center for Catalysis and scientists at Oxford University has produced a new approach for understanding surfaces, particularly metal oxide surfaces, widely used in industry...
|
|
|
Osteologix to Present at 12th Annual BIO CEO & Investor Conference
- Osteologix, Inc.(OTCBB:OLGX) today announced that Philip J. Young, President and CEO of Osteologix, will present a corporate overview and update at the 12th Annual BIO CEO & Investor Conference being held this week at the Waldorf Astoria Hotel in New...
|
|
|
Osteologix to Present at 12th Annual BIO CEO & Investor Conference
GLEN ALLEN, Va.--(BUSINESS WIRE)--Osteologix, Inc.(OTCBB: OLGX.OB) today announced that Philip J. Young, President and CEO of Osteologix, will present a corporate overview and update at the 12th Annual BIO CEO & Investor Conference being held this week...
|
|
|
Osteologix to Present at 12th Annual BIO CEO & Investor Conference
Companies mentioned in this article: Osteologix, Inc.GLEN ALLEN, Va. -- (BUSINESS WIRE) -- Osteologix, Inc. (OTCBB:OLGX) today announced that Philip J. Young, President and CEO of Osteologix, will present a corporate overview and update at the 12th...
|
|
|
Radiation for AMD Trials Advance
Current treatment for neovascular age-related macular degeneration includes intravitreal injections of bevacizumab (Avastin) or ranibizumab (Lucentis), every four weeks.Lucentis is approved by the Food and Drug Administration for the treatment of AMD;...
|
